Skip to main content
. Author manuscript; available in PMC: 2010 Jun 9.
Published in final edited form as: Rev Endocr Metab Disord. 2010 Mar;11(1):61–74. doi: 10.1007/s11154-010-9134-4

Table 2.

Implications for management from studies of endothelial function in diabetes

No benefit from traditional antioxidants (vitamin E and vitamin C)
ACE inhibitors and ARB’s preferred
Statin therapy beneficial
Intensive glucose control/Insulin sensitizers should be beneficial
Merit further clinical study:
 PKCβ inhibitors
 NFκB inhibitors
 Mitochondrial directed therapy—inhibit fission, augment fusion
    and autophagy
 Practical methods to monitor endothelial function